ALEC
Alector, Inc.NASDAQHealthcare$2.41-4.74%ClosedMarket Cap: $266.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
7.88
P/S
12.30
EV/EBITDA
-1.68
DCF Value
$-0.24
FCF Yield
-71.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
89.3%
Operating Margin
-692.8%
Net Margin
-679.2%
ROE
-225.0%
ROA
-48.7%
ROIC
-62.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $6.2M | 63.8% | $-29.4M | $-37.3M | $-0.34 | — |
| FY 2025 | $21.0M | 54.1% | $-145.8M | $-142.9M | $-1.39 | — |
| Q3 2025 | $3.3M | 100.0% | $-37.6M | $-34.7M | $-0.34 | — |
| Q2 2025 | $7.9M | 100.0% | $-34.1M | $-30.5M | $-0.30 | — |
| Q1 2025 | $3.7M | 100.0% | $-44.7M | $-40.5M | $-0.41 | — |
| Q4 2024 | $54.2M | 14.3% | $-7.2M | $-2.1M | $-0.02 | — |
| FY 2024 | $100.6M | 100.0% | $-145.0M | $-119.0M | $-1.23 | — |
| Q3 2024 | $15.3M | 100.0% | $-48.4M | $-42.2M | $-0.44 | — |
| Q2 2024 | $15.1M | 84.9% | $-45.6M | $-38.7M | $-0.40 | — |
| Q1 2024 | $15.9M | 85.6% | $-43.7M | $-36.1M | $-0.38 | — |
| Q4 2023 | $15.2M | 85.1% | $-47.5M | $-41.4M | $-0.49 | — |
| FY 2023 | $97.1M | 90.9% | $-151.7M | $-130.4M | $-1.56 | — |